A new study has found that taking a regular steroid inhaler can reduce the risk of severe symptoms of COVID-19.
The research, published in the Lancet, aimed to understand whether existing lung conditions make people more severely ill with COVID-19 and whether medication for these conditions has an impact.
The researchers collected information from 75,463 people admitted to hospital with COVID-19 in the UK between 17 January 2020 and 3 August 2020. They looked at whether the person had asthma, chronic pulmonary disease, or both. They also collected information on their age, the medication they were taking, what treatment they received for COVID-19 and whether they died.
The results found that underlying lung conditions were common in people admitted to hospital for COVID-19. Specifically, the authors found that:
As we learn more about COVID-19, it is crucial to understand why some people become more ill and require hospital treatment, compared to others. This study helps us understand how underlying lung conditions could affect the course of the infection. A key finding shows that regular use of steroid inhalers could help to reduce the risk of death for older people with asthma.
Title: Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Learn about the factors that can cause lung disease and the ways to reduce your contact with them.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.